Skip to main content

CFIA-AIRS Updates February 14, 2024

Chapter 30

Chapter 30 was published to:

i) change the release recommendation from “Refer to CFIA-NISC” to “Refuse Entry” for the following HS codes with the end uses “Commercial”, “Industrial Use (i.e. is not commercial use)”, “Manufacturing”, “Other End Uses” and “Scientific Use (Research)” originating from Andorra, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Ceuta and Melilla, Faroe Islands, Georgia, Gibraltar, Greenland, Guernsey, Holy See (Vatican City State), Isle of Man, Jersey, Republic of Kosovo, Liechtenstein, Republic of Moldova, Monaco, Montenegro, North Macedonia, Russian Federation, Saint Pierre and Miquelon, San Marino, Serbia, Svalbard and Jan Mayan, Türkiye, and Ukraine:

30.02.12.1095.10 – Bulk fetal bovine serum and plasma or derivatives, dried or liquid.
30.02.12.1095.11 – Bulk bovine serum, plasma or derivatives, dried or liquid.
30.02.12.1095.14 – Bulk ruminant serum (other than bovine), plasma or derivatives, dried or liquid.

ii) change the release recommendation from “Refer to CFIA-NISC” to “Refuse Entry” for the following HS codes with the end use “Other End Uses” originating from Andorra, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Ceuta and Melilla, Faroe Islands, Georgia, Gibraltar, Greenland, Guernsey, Holy See (Vatican City State), Isle of Man, Jersey, Republic of Kosovo, Liechtenstein, Republic of Moldova, Monaco, Montenegro, North Macedonia, Russian Federation, Saint Pierre and Miquelon, San Marino, Serbia, Svalbard and Jan Mayan, Türkiye, and Ukraine:

30.02.12.1095.07 – Blood, serum, plasma or derivatives for in vitro use – ruminant – other than bovine.
30.02.12.1095.13 – Blood, serum, plasma or derivatives for in vitro use – fetal bovine serum.
30.02.12.1095.21 – Blood, serum plasma or derivatives for in vitro use – bovine.

iii) modify the import conditions for the following HS codes with the end uses “Commercial”, “Industrial Use”, “Manufacturing”, “Other End Uses” and “Scientific Use (Research)” originating from Iceland, Norway, Switzerland, and United Kingdom:

30.02.12.1095.10 – Bulk fetal bovine serum and plasma or derivatives, dried or liquid.
30.02.12.1095.11 – Bulk bovine serum, plasma or derivatives, dried or liquid.
30.02.12.1095.14 – Bulk ruminant serum (other than bovine), plasma or derivatives, dried or liquid.

iv) modify the import conditions for the following HS codes with the end use “Other End Uses” originating from Iceland, Norway, Switzerland, and United Kingdom:

30.02.12.1095.07 – Blood, serum, plasma or derivatives for in vitro use – ruminant – other than bovine.
30.02.12.1095.13 – Blood, serum, plasma or derivatives for in vitro use – fetal bovine serum.
30.02.12.1095.21 – Blood, serum plasma or derivatives for in vitro use – bovine.

If you have any questions, please contact your National Import Service Centre.

Topic(s)

Other Government Departments (OGDs) Requirements
Release
Release - General
System Updates/Outages & Delays at the Border

Information source

Canadian Food Inspection Agency (CFIA)
Disclaimer

The foregoing information is provided for informational purposes only and is not intended as, nor should it be considered, professional advice or a substitute for conducting your own thorough research and review. Before making any decisions or taking any action based on the information provided, you should conduct your own independent investigation and/or seek professional advice from a qualified expert in the relevant field. The CSCB disclaims all liability for actions taken or not taken based on the information provided.